Your browser is no longer supported. Please, upgrade your browser.
Biofrontera Inc.
Index- P/E- EPS (ttm)-1.30 Insider Own69.00% Shs Outstand11.05M Perf Week211.02%
Market Cap87.30M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.60M Perf Month-
Income-10.40M PEG- EPS next Q- Inst Own- Short Float0.00% Perf Quarter-
Sales19.00M P/S4.59 EPS this Y0.00% Inst Trans- Short Ratio0.00 Perf Half Y-
Book/sh-0.17 P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh0.43 P/C18.57 EPS next 5Y- ROE- 52W Range2.25 - 7.36 Perf YTD79.14%
Dividend- P/FCF- EPS past 5Y- ROI-166.70% 52W High7.34% Beta-
Dividend %- Quick Ratio1.90 Sales past 5Y- Gross Margin51.20% 52W Low251.10% ATR0.99
Employees56 Current Ratio4.00 Sales Q/Q143.80% Oper. Margin- RSI (14)- Volatility27.79% -
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume7.61 Prev Close5.22
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume13.57M Price7.90
Recom- SMA20136.83% SMA50136.83% SMA200136.83% Volume103,286,499 Change51.34%
Nov-24-21 10:45AM  
Nov-23-21 08:15AM  
Nov-16-21 09:03AM  
Nov-02-21 02:45PM  
Oct-28-21 09:40PM  
Oct-14-21 06:31AM  
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.